Jo MD - RenovaCare Chief Officer
RCAR Stock | USD 0.0001 0.00 0.00% |
Insider
Jo MD is Chief Officer of RenovaCare
Phone | 888 398 0202 |
Web | https://www.renovacareinc.com |
RenovaCare Management Efficiency
The company has return on total asset (ROA) of (1.0399) % which means that it has lost $1.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.689) %, meaning that it created substantial loss on money invested by shareholders. RenovaCare's management efficiency ratios could be used to measure how well RenovaCare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Noel MBA | PepGen | 54 | |
MD MBA | Rezolute | N/A | |
CPA MBA | Pharvaris BV | 63 | |
David Mack | Pmv Pharmaceuticals | 62 | |
Deepika PharmD | Pmv Pharmaceuticals | 48 | |
Anne Lesage | Pharvaris BV | 63 | |
Kyle Breidenstine | PepGen | N/A | |
Joan JD | Pharvaris BV | 60 | |
Hunter MD | Aerovate Therapeutics | 58 | |
LLM JD | Rezolute | 63 | |
Annick Deschoolmeester | Pharvaris BV | 51 | |
James McArthur | PepGen | 62 | |
Peter Rhode | HCW Biologics | 66 | |
Fangyong Du | Adagene | 54 | |
Niels Svenstrup | PepGen | 54 | |
Brian MD | Rezolute | 49 | |
Jennifer Cormier | PepGen | N/A | |
Alexander Zurcher | Molecular Partners AG | 49 | |
Man MBA | Adagene | 47 | |
Scott Anderson | Anebulo Pharmaceuticals | N/A | |
Leila MD | Pmv Pharmaceuticals | 61 |
Management Performance
Return On Equity | -5.69 | |||
Return On Asset | -1.04 |
RenovaCare Leadership Team
Elected by the shareholders, the RenovaCare's board of directors comprises two types of representatives: RenovaCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RenovaCare. The board's role is to monitor RenovaCare's management team and ensure that shareholders' interests are well served. RenovaCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RenovaCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Treasurer | ||
Robin Robinson, VP Board | ||
Harmel Rayat, Chairman of the Board | ||
Alan Rubino, Consultant | ||
Jo MD, Chief Officer |
RenovaCare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is RenovaCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -5.69 | |||
Return On Asset | -1.04 | |||
Current Valuation | 3.42 M | |||
Shares Outstanding | 87.35 M | |||
Shares Owned By Insiders | 74.18 % | |||
Price To Earning | (85.28) X | |||
Price To Book | 5.11 X | |||
EBITDA | (4.46 M) | |||
Net Income | (4.47 M) | |||
Cash And Equivalents | 243.96 K |
Pair Trading with RenovaCare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RenovaCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovaCare will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to RenovaCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RenovaCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RenovaCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RenovaCare to buy it.
The correlation of RenovaCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RenovaCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RenovaCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RenovaCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for RenovaCare Pink Sheet Analysis
When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.